Wednesday, December 31, 2014

Tick removal product

Here is what is in the tick releaser spray:

Ingredients: Clove oil, lemongrass oil, purified water, almond oil, glycerin.

The new Tick Releaser Spray & Test Kit took top honors by winning the Gold Product Innovation award at Backer’s Total Pet Expo 2014. The kit provides not only a means to safely remove ticks, but also to send them in for diagnostic testing to rule out the possibility of disease transmission.

The new Tick Releaser Spray & Mail-In Test Kit from Earth’s Balance is an all-encompassing solution. It’s a convenient, cost-effective means to protect pets and family. After the tick has been safely removed, it is a good idea to have it tested to ensure it does not carry debilitating disease.

The kit itself includes: releaser spray (made with all-natural essential oils), tweezers, collection tube, alcohol prep pad and mail-in diagnostic testing order form. All-natural and toxin-free, it provides a means to release ticks quickly, safely and intact. Simply spray, tweeze and collect. Then fill out the order form and mail the tick in for your selected diagnostic tests.

For an additional fee, ticks can be submitted and tested for the following diseases: Lyme disease, Anaplasma, Babesia, Ehrlichia,  Bartonella, Rocky Mountain Spotted Fever and Tularemia. Prices range from $25 for one disease up to $75 for a total panel of all seven diseases.

Tick Releaser Spray & Mail-In Test Kit will be available in stores and online in early spring. For more information, visit or call 1-800-292-3424.

* * * * * *

Ticks can be submitted and tested for the following diseases: Anaplasma, Babesia, Ehrlichia, Lyme disease, Bartonella, Rocky Mountain Spotted Fever and Tularemia. Lab testing fees range from $25 for one disease up to $75 for a total panel of all seven diseases.

For more information, visit  Dealers and retailers interested in carrying Earth’s Balance Tick Releaser and  Mail-In Test Kit should email sales representative Jason Reid at

* * * * *

The first ad says the tick is mailed to Research Associates Laboratory.   It is located in Dallas, Texas.

Here's the information from the company's about page:

Since 1992 Research Associates laboratory has been providing state of the art molecular diagnostics to veterinarians, zoos, universities, restaurants, hotels, and the pet and pest industries. We are the nation's oldest and most experienced veterinary molecular diagnostic laboratory.

We are the only diagnostic laboratory offering affordable next day results 6 days per week.

Laboratory Director

    Ernie Colaizzi


    (972) 960-2221
    (972) 960-1997
    14556 Midway Road Dallas, TX 75244 (Google Map)

* * * *
The lab offers what's called "Real Time PCR testing."
* * * *

So apparently, Earth's Balance (, which is a subsidiary of Marshall Pet Products ( seems to have teamed with a vet lab for the tick testing. The out-of-the gate marketing is clearly for hunters and other people who spend time in the woods.

Saturday, December 27, 2014

Sexual transmission of Lyme disease

Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions [v1; ref status: awaiting peer review,]

Marianne J. Middelveen1, Jennie Burke2, Eva Sapi3, Cheryl Bandoski3, Katherine R. Filush3, Yean Wang2, Agustin Franco2, Arun Timmaraju3, Hilary A. Schlinger1, Peter J. Mayne1, Raphael B. Stricker1


Background: Recent reports indicate that more than 300,000 cases of Lyme disease are diagnosed yearly in the USA. Preliminary clinical, epidemiological and immunological studies suggest that infection with the Lyme disease spirochete Borrelia burgdorferi (Bb) could be transferred from person to person via intimate human contact without a tick vector. Detecting viable Borrelia spirochetes in vaginal and seminal secretions would provide evidence to support this hypothesis.

Methods: Patients with and without a history of Lyme disease were selected for the study after informed consent was obtained. Serological testing for Bb was performed on all subjects. Semen or vaginal secretions were inoculated into BSK-H medium and cultured for four weeks. Examination of genital cultures and culture concentrates for the presence of spirochetes was performed using light and darkfield microscopy, and spirochete concentrates were subjected to Dieterle silver staining, anti-Bb immunohistochemical staining, molecular hybridization and PCR analysis for further characterization. Immunohistochemical and molecular testing was performed in three independent laboratories. Positive and negative controls were included in all experiments.

Results: Control subjects who were asymptomatic and seronegative for Bb had no detectable spirochetes in genital secretions by PCR analysis. In contrast, spirochetes were observed in cultures of genital secretions from 11 of 13 subjects diagnosed with Lyme disease, and motile spirochetes were detected in genital culture concentrates from 12 of 13 Lyme disease patients using light and darkfield microscopy. Morphological features of spirochetes were confirmed by Dieterle silver staining and immunohistochemical staining of culture concentrates. Molecular hybridization and PCR testing confirmed that the spirochetes isolated from semen and vaginal secretions were strains of Borrelia, and all cultures were negative for treponemal spirochetes. PCR sequencing of cultured spirochetes from three couples having unprotected sex indicated that two couples had identical strains of Bb sensu stricto in their semen and vaginal secretions, while the third couple had identical strains of B. hermsii detected in their genital secretions.

Conclusions: The culture of viable Borrelia spirochetes in genital secretions suggests that Lyme disease could be transmitted by intimate contact from person to person.

Wednesday, December 24, 2014

Save A Dog, Inc. News » Lyme Prevention

Here's what appears to be very helpful website about Lyme disease prevention, specifically about how dogs play into your strategy of prevention. There is a lot of veterinary information here and some straight talk about how to protect yourself and your dog from acquiring Lyme.


New iSpot Lyme Test

  • iSpot Lyme: A New Generation of Lyme Disease Testing

    The iSpot Lyme™ assay is a new generation of in vitro diagnostic test for the detection of antigen-specific effector/memory T cells that respond to stimulation by ...
  • iSpotLyme - For greater accuracy, request iSpot Lyme™
    The iSpot Lyme test allows for earlier detection and increases accuracy because it detects the bacterial infection that accompanies Lyme disease. Find out how ...
  • New T-Cell Test a "Game-Changer" for Lyme
    Aug 30, 2013 - The iSpot Lyme test is far more sensitive and specific than the standard Western Blot, which despite it's limitations, remains a cornerstone of the ...
  • lyme positive result on ispot lyme test - MDJunction

    Mar 29, 2013 - lyme positive result on ispot lyme test: Hello, I am new to this forum...I have fibro/CFS for 4 years now. Finally got someone to do Lyme ...
  • Assessing Lyme Disease: Using the iSpot™ Lyme Test ...

    ► 17:14► 17:14
    Apr 11, 2013 - Uploaded by neuroscienceinc
    Presented by: Joe Ailts, Director of Medical Education Undiagnosed or undertreated Lyme disease may result in ...
  • Pharmasan Labs introduces iSpot Lyme - New Hope 360 › Supply News & Analysis
    Apr 2, 2013 - The iSpot Lyme test represents a breakthrough in diagnostic accuracy, leading to faster diagnosis and treatment.
  • Thursday, December 18, 2014

    Breaking News - NYS Bill Signed into Law - Chapter 532

    This letter from a Lyme activist in NY is in reference to the bill that just passed NY State legislature in support of ILADS standard of care for NY citizens who have Lyme disease and desire long-term antibiotic treatment. (See post earlier today.)


    To All,
    WE DID IT!
    The memo will be issued and the chapter amendment may or may not be available until Jan. We were told that we will be very happy, it is strong! 
    It was our ability to work together that we were able to educate the NYS government to the dire need for sick people to be treated as individuals, especially when the science on persistence of borreliosis (Lyme and other borrelia) is not settled. 
    Our NYS Coalition on Lyme and Tickborne diseases worked with Support Groups, patients, reporters, researchers, scientists, physicians, state and federal reprersentatives and others. It is with great thanks to ALL OF YOU for your support, letters, calls and whatever you did to help.We are powerful together and we made a difference! Give yourselves a round of applause.
    Way too many people  have suffered needlessly. The limited number of physicians who were willing to treat us with compassion, were those who had the most difficult complicated cases; the discards of other physicians. They are the ones with the experience, knowledge and skill who risked their very licenses to give so many their lives back again and reduce illness. Yet they were constantly harassed by unwarranted, costly investigations by the NYS Office of Professional Medical  Conduct. Understandably this had a chilling effect on other doctors willingness to treat patients as individuals beyond the 2-4 week outdated IDSA Guideline.
    It is unconscionable, in the light of this that sick people have been turned away and allowed to suffer endlessly without hope. Some Tickborne disease patients even died from lack of medical care. Two I know about within 10 miles of my home are a 17 year old, and a mother; they both are in their graves. Let this be a turning point!
     NYS, the Empire State, is putting a line in the sand to say, that's enough!

    Dietary Supplements Containing Live Bacteria or Yeast in Immunocompromised Persons: Warning - Risk of Invasive Fungal Disease

    Safety Alerts for Human Medical Products 

    Here is the content from another source.  It was not the bacteria intended to be in the product that was the problem, but rather a contaminant.  However, the FDA is saying new product application wanted.  Does this mean they are going to be regulating probiotics???
    Dietary Supplements Containing Live Bacteria or Yeast in Immunocompromised Persons: Warning - Risk of Invasive Fungal Disease
    December 9, 2014

    Audience: Health Professional, Pediatrics , Internal Medicine, Consumer

    [Posted 12/09/2014]

    ISSUE: FDA is warning health professionals of the risks associated with the regarding use of dietary supplements containing live bacteria or yeast in immunocompromised persons. A premature infant administered a dietary supplement, ABC Dophilus Powder (Solgar), as part of in-hospital course of treatment, developed gastrointestinal mucormycosis caused by the mold Rhizopus oryzae and died. Rhizopus oryzae mold was found to be present as a contaminant in an unopened container of the ABC Dophilus Powder, which is formulated to contain three species of live bacteria.

    FDA, along with the Centers for Disease Control and Prevention (CDC) and the Connecticut Department of Public Health, are investigating the death of this preterm infant who developed gastrointestinal mucormycosis.  In mid-November, Solgar issued a recall for certain lots of ABC Dophilus Powder and public health warnings were issued advising customers and consumers not to use the recalled product.

    FDA is informing healthcare providers that dietary supplements, including those that are formulated to contain live bacteria or yeast, are generally not regulated as drugs by the FDA.  As such, these products are not subject to FDA's premarket review or approval requirements for safety and effectiveness, nor to the agency's rigorous manufacturing and testing standards for drugs, including testing for extraneous organisms.

    BACKGROUND: FDA is warning health professionals of the potential risks associated with the use of dietary supplements containing live bacteria or yeast in immunocompromised persons. Gastrointestinal mucormycosis primarily occurs in immunocompromised persons, such as prematurely born infants.

    RECOMMENDATION: FDA advises practitioners to approach the application of these interventions with caution. FDA encourages health care providers who use dietary supplements containing live bacteria or yeast as drugs (e.g., to treat, mitigate, cure, or prevent a disease or condition) to submit an Investigational New Drug Application (IND) for FDA review

    Health care providers and consumers are encouraged to report adverse events following use of dietary supplements both to the manufacturer using the address or phone number which is required to be on the product label and to the FDA. Visit to submit a report online, or call 1-800-FDA-1088.

    [12/09/2014 - Dear Healthcare Provider Letter - FDA]

    NY State Passes New Law on Antibiotics

    December 18, 2014

    Doctors who prescribe longer courses of antibiotic treatments for Lyme disease have new protections under state law today.

    Gov. Andrew Cuomo signed a bill late Wednesday that prohibits the state Office of Professional Medical Conduct from investigating a licensed physician based solely upon the recommendation or provision of a treatment that is not universally accepted by the medical profession.

    Full story



    NY Governor has Signed the Lyme Bill !!

    This is fantastic news for New York residents! It also sets a precedent for other states.  



    Governor Cuomo signed the Patients' Rights/ Doctor Protection bill this evening (12/17/14)!  The bill provides that the OPMC may not charge a physician or other medical licensee with misconduct solely for recommending or providing treatments that are not universally accepted by the medical profession, including, but not limited to, treatments for Lyme disease.

    This law has been a long time in coming, but it's done!  There may be some technical tweaks, but we are assured that they do not alter the intent of the bills that were unanimously passed in both Senate and Assembly.

    THANK YOU TO EVERY ONE OF YOU WHO CONTACTED (and recontacted) THE GOVERNOR'S OFFICE!!  That effort made the difference!  Thousands of Lyme victims told their stories and the legislative staffers and Governor Cuomo's staff, none of whom really knew much about Lyme to start with, now know more than they ever thought possible. And they now understand what the fuss is all about. This would not have happened without you all.  Pat yourselves on the back -- this is YOUR law.

    Feel free to send a note of thanks to Governor Cuomo, Senator Kemp Hannon, Assemblywoman Didi Barrett, and Assemblyman Richard Gottfried for their dedication to this cause.  

    We will send more details as they become available.

    Best regards to everyone!

    Chris Fisk
    Lyme Action Network

    Friday, December 12, 2014

    Damage of Collagen and Elastic Fibres by Borrelia Burgdorferi - Known and New Clinical and Histopathological Aspects

    In the last year or so I have noticed a rapid loss of elasticity in my own skin. Coincident with this, I had a positive culture test result from Advanced Laboratory Services for Borrelia meaning that even after years of antibiotic therapy both oral and intravenous, I still have active Borrelia in my blood. Over the ten or so years of my reading about Lyme disease and related conditions, I've seen references in the literature about Bartonella affecting skin. However, those have mostly been about degradation or destruction of surface capillaries visible in the skin.  I've had plenty of that as well in the last year. This paper addresses the issue of loss of elasticity and collagen of the skin as a result of infection by Borrelia rather than Bartonella. Specifically, it references loss of collagen as well as connective soft tissues such as tendons and ligaments and even the dislocation of the spinal vertebrae that can result when critical connective tissues begin to lose strength. - Bob

    Damage of Collagen and Elastic Fibres by Borrelia Burgdorferi - Known and New Clinical and Histopathological Aspects

    Muller, KE. Damage of Collagen and Elastic Fibres by Borrelia Burgdorferi – Known and New Clinical and Histopathological Aspects.
    Open Neurol J. 2012; 6: 179–186.
    Lyme Borreliosis, or Lyme disease, manifests itself in numerous skin conditions. Therapeutic intervention should be initiated as soon as a clinical diagnosis of erythema migrans is made. The histopathology of some of the skin conditions associated with Lyme Borreliosis is characterised by structural changes to collagen, and sometimes also elastic fibres. These conditions include morphea, lichen sclerosus et atrophicus and acrodermatitis chronica atrophicans. More recently, further skin conditions have been identified by the new microscopic investigation technique of focus floating microscopy: granuloma annulare, necrobiosis lipoidica, necrobiotic xanthogranuloma, erythema annulare centrifugum, interstitial granulomatous dermatitis, cutaneous sarcoidosis and lymphocytic infiltration; these conditions also sometimes cause changes in the connective tissue. In the case of ligaments and tendons, collagen and elastic fibres predominate structurally. They are also the structures that are targeted by Borrelia. The resultant functional disorders have previously only rarely been associated with Borreliosis in clinical practice. Ligamentopathies and tendinopathies, spontaneous ruptures of tendons after slight strain, dislocation of vertebrae and an accumulation of prolapsed intervertebral discs as well as ossification of tendon insertions can be viewed in this light.

    Thursday, December 11, 2014

    Update on persistent symptoms associated with Lyme disease. - PubMed - NCBI

    If you like reading medical studies or abstracts (much easier to read the abstracts, IMHO, but you can miss the nuances in the detailed publication if you do), here's an interesting/annoying one supposedly proving that Lyme bacteria do not persist in the human body after basic treatment with oral antibiotics. Of course, this topic is THE pivotal argument going on between the IDSA and ILADS docs and researchers. There are other areas of contention, yes, but this argument determines health insurance company policy, standards of care that affect virtually anyone diagnosed with Lyme, and especially chronic Lyme. A study such as this can truly have life-or-death consequences for those of us living with chronic Lyme disease. 

    -Bob Cowart

    Curr Opin Pediatr. 2014 Dec 7. [Epub ahead of print]
    Update on persistent symptoms associated with Lyme disease.
    Oliveira CR, Shapiro ED.


    Curr Opin Pediatr. 2014 Dec 7. [Epub ahead of print]

    Update on persistent symptoms associated with Lyme disease.

    Oliveira CR1, Shapiro ED.

    Author information


    Lyme disease, caused by Borrelia burgdorferi, is the most common 
    vector-borne illness in the United States. The pathogenesis, ecology, 
    and epidemiology of Lyme disease have been well described, and 
    antimicrobial treatment is very effective. There has been controversy 
    about whether infection can persist and cause chronic symptoms despite 
    treatment with antimicrobials. This review summarizes recent studies 
    that have addressed this issue.


    The pathogenesis of persistent nonspecific symptoms in patients who were 
    treated for Lyme disease is poorly understood, and the validity of 
    results of attempts to demonstrate persistent infection with B. 
    burgdorferi has not been established. One study attempted to use 
    xenodiagnosis to detect B. burgdorferi in patients who have been treated 
    for Lyme disease. Another study assessed whether repeated episodes of 
    erythema migrans were due to the same or different strains of B. 
    burgdorferi. A possible cause of persistent arthritis in some treated 
    patients is slow clearance of nonviable organisms that may lead to 
    prolonged inflammation. The results of all of these studies continue to 
    provide evidence that viable B. burgdorferi do not persist in patients 
    who receive conventional antimicrobial treatment for Lyme disease.


    Patients with persistent symptoms possibly associated with Lyme disease 
    often provide a challenge for clinicians. Recent studies have provided 
    additional evidence that viable B. burgdorferi do not persist after 
    conventional treatment with antimicrobials, indicating that ongoing 
    symptoms in patients who received conventional treatment for Lyme 
    disease should not be attributed to persistent active infection.


         [PubMed - as supplied by publisher]

    Response to the study, by Carl Tuttle,  US-based Lyme activist, challenging the accuracy of the study:

    Dec 11, 2014
    LWW Business Offices 
    250 Waterloo Road
    SE1 8RD
    United Kingdom
    Attn: Richard B. Johnston, Jr., MD Editor-in-Chief,      
    Current Opinion in Pediatrics
    Current Opinion in Pediatrics
    Dear Dr Johnston,
    In reference to the Shapiro article, "Update on persistent symptoms associated with Lyme disease" I would like to point out that the CDC criteria for positive serologic results require five out of ten IgG bands on the Western blot. In contrast, a single band criterion in China is sufficient to diagnose Lyme disease.(1)
    The CDC's positive case definition for Lyme disease (five out of ten bands) was created for surveillance/reporting purposes only but is routinely responsible for misdiagnosis. A recent paper published in the International Journal of Molecular Sciences (2) identified the misdiagnosis of a sixteen year old (Patient #3who was hospitalized for pure psychiatric illnesses at a psychiatric hospital for seven weeks. The boy's Western blot identified only four out of five positive bands so the so-called "Lyme expert" mislabeled the teenager as a psychiatric patient and the boy was hospitalized without proper treatment of the infectious agents.
    The correct diagnosis was made through the use of DNA sequencing positive for B. burgdorferi identifying the infectious agents in the patient's blood. I would like to point out that this patient failed a previous treatment following the recommended one-size-fits-all IDSA treatment guideline for Lyme disease; identifying persistent infection.
    Shapiro's so-called expert opinion ("antimicrobial treatment is very effective") does not hold true in this case. I would like to call attention to Shapiro's additional misleading Lyme disease comments previously archived on the Internet:

    Per the U.S. Food and Drug Administration website there appears to be four pages of patient complaints regarding faulty/misleading Lyme disease antibody testing and subsequent misdiagnosis.(3)
    Current misleading serology is frequently responsible for delayed diagnosis and often used to deny insurance reimbursement. Yale University Schools of Medicine and of Public Health prefers to turn a blind eye to these facts as Shapiro has had a career long bias against persistent infection. Any lab test outside of serology threatens that bias.
    Respectfully submitted,
    Carl Tuttle                                                       
    Hudson, NH
    Attachment: Dr David J. Volkman's letter to Dr. Thomas Frieden, Director of the CDC.
    [1] A Study of the Technique of Western Blot for Diagnosis of Lyme Disease caused by Borrelia afzelii in China
    [2] DNA Sequencing Diagnosis of Off-Season Spirochetemia with Low Bacterial Density in Borrelia burgdorferi and Borrelia miyamotoi Infections
    [Please be advised that there is an error in the paper; CORRECTION: "negative IgM and positive IgG for 4 bands" NOT 6 as verified by Dr Lantsman]
    [3] MAUDE - Manufacturer and User Facility Device Experience

    Transfusion-associated Anaplasma phagocytophilum infection in a pregnant patient

    *Transfusion-associated /Anaplasma phagocytophilum/ 
    infection in a pregnant patient with thalassemia trait: a
    case report. *
    Shields K, Cumming M, Rios J, Wong MT, Zwicker JI, Stramer
    SL, Alonso CD.
    /Transfusion/, online before print, 2014 Nov 11.

    Human granulocytic anaplasmosis (HGA) is an acute
    nonspecific febrile illness caused by the bacterium
    /Anaplasma phagocytophilum/. Although usually transmitted
    via tick bite, HGA may rarely also be acquired through
    transfusion. HGA during pregnancy may pose significant
    gestational risks due to altered maternal immune status and
    the potential for perinatal transmission.

    *Case Report*
    A pregnant 34-year-old Massachusetts woman with
    β-thalassemia trait was diagnosed at 32 weeks of gestation
    with transfusion-associated HGA (TAHGA) after receiving nine
    leukoreduced red blood cell transfusions. She was
    successfully treated with rifampin therapy and gave birth to
    a healthy child who tested negative for HGA after delivery.
    An implicated blood donor was subsequently identified
    through physician collaboration with the regional American
    Red Cross and Massachusetts Department of Public Health.

    This is the 11th reported case of HGA in pregnancy and is at
    least the sixth known case in which leukoreduction did not
    prevent TAHGA. As seen in this case, nonspecific
    symptomatology of variable onset can impede diagnosis and
    treatment. This may increase risk of poor outcomes in
    maternal HGA patients. Cases of TAHGA, although currently
    uncommon, may increase as the incidence of HGA in certain
    parts of the country increases.

    Heightened cross-institutional awareness of the potential
    risk of TAHGA is warranted. Clinicians need to consider
    transfusion-associated infections when fever occurs in a
    transfusion recipient. This case provides additional
    evidence that leukoreduction does not obviate risk of /A. 
    phagocytophilum/ contamination of donated blood components.

    Sunday, December 7, 2014

    Fibromyalgia in Patients with Culture-Confirmed Lyme Disease

    It looks from this study as though Lyme and Fibromyalgia are not highly correlated, suggesting that Lyme does not cause FM, as some have speculated.


    Long-Term Assessment of Fibromyalgia in Patients with Culture-Confirmed Lyme Disease
    Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Farber S, Prakash P, Ash J, Nowakowski J.
    Arthritis & Rheumatology, online first, 2014 Dec 2.


    Background: Fibromyalgia occurs in 2% to 8% of the general population. One of the triggers may be Lyme disease.

    Methods: Patients with culture-confirmed Lyme disease who originally presented with erythema migrans have been evaluated annually in a prospective study to determine their long-term outcome. In 2011-2013, subjects were evaluated for fibromyalgia by interview and tender point examination.

    Results: 100 subjects were assessed, 52% of whom were male; the mean age was 64.9 years (median 64 years, range 42-86 years). The mean duration of follow-up was 15.4 years (median 16 years, range 11-20 years). At least twenty-four (24%) subjects had experienced a second episode of erythema migrans before the evaluation for fibromyalgia. One patient (1%, 95% C.I.: 0.025 to 5.4%) met criteria for fibromyalgia. The symptoms consistent with fibromyalgia began more than 19 years after Lyme disease was diagnosed.

    Conclusions: Fibromyalgia was observed in only 1% of 100 patients with culture-confirmed early Lyme disease, a frequency consistent with that found for the general population.

    Tick testing company

    Here's a tip for getting ticks tested for Lyme and coinfections, cheap. Saw this on a listserv today, from a naturopath:

    I have been using the tic-kits.  I do have a contact person if you would like to speak to someone about it.  I have tested a few ticks with these.  They test for borrelia, bartonella, anaplasma and ehrlichia.  The test is pretty inexpensive, at $45 for all 4 infections.  I have been using the lab who sold me the kits, Pharmasan labs, for many years.  I find them reliable.  

    Friday, December 5, 2014

    Military Lyme Support group

    35 messages added in the last 7 days

    Group Description

    Military Lyme Support® was Founded in 2002 by a USAF Spouse who found it impossible to get adequate treatment for Lyme and Co-infections at her local Military Treatment Facility. This site is a source for information and emotional support for ALL Members of the Armed Forces: Veterans, Active Duty, Reserve, Family and Caregivers. 

    To date, Lyme and other vector-borne diseases are often unrecognized, misdiagnosed, and untreated. Lyme is known as the "Great Imitator" and Doctors often prefer more familiar diagnoses like GWS, FM, CFS, XMRV, Lupus, Sjogrens, MS, RA, ALS, Autism, ADHD, or Mental Illness, just to name a few. This "cook-book" diagnostic approach leaves our Members with untreated, chronic diseases that can cause complete disability.

    Military Lyme Support empowers our Members to get the cutting-edge treatment they need to overcome their illnesses via the ILADS Treatment Guidelines. Doctor referrals, VA, MTF and Tricare advice is also provided.

    Please Note: You can test negative multiple times, and still be infected, as the currently available tests are grossly unreliable and inaccurate. If you have a rash, you are CDC positive for Lyme Disease...even if you test negative!

    DISCLAIMER: All information posted on this site is the opinion of the author(s)alone and is provided for educational purposes only. It is not to be construed as medical advice regarding the treatment of any symptoms or disease. You should obtain the medical advice of your personal physician before pursuing any treatment mentioned here.

    Thursday, December 4, 2014

    Jailed for Lyme Disease. Really? Really.

    Become a fan Award-winning professional photographer
     From Huff Post, Dec 4, 2014
     Posted: Updated:

    We've all heard this before, and many of us know it firsthand to be true. Disease is unfair, and it strikes us without warning or discretion. Yet there is one thing we have come to expect from living in the United States -- that the medical and legal systems are here to support us all equally and fairly. Sounds great in theory, but when put to the test, if you're a round peg, good luck fitting in the square hole.

    Wednesday, December 3, 2014

    Implants to stop Lyme disease??

    MEDFORD/SOMERVILLE, Mass. (Nov. 24, 2014) -- Researchers at Tufts University, in collaboration with a team at the University of Illinois at Champaign-Urbana, have demonstrated a resorbable electronic implant that eliminated bacterial infection in mice by delivering heat to infected tissue when triggered by a remote wireless signal.  The silk and magnesium devices then harmlessly dissolved in the test animals. The technique had previously been demonstrated only in vitro. The research is published online in the Proceedings of the National Academy of Sciences Early Edition the week of November 24-28, 2014.

    "This is an important demonstration step forward for the development of  on-demand medical devices that can be turned on remotely to perform a therapeutic function in a patient and then safely disappear after their use, requiring no retrieval," said senior author Fiorenzo Omenetto, professor of biomedical engineering and Frank C. Doble professor at Tufts School of Engineering. "These wireless strategies could help manage post-surgical infection, for example, or pave the way for eventual 'wi-fi' drug delivery."

    - See more at:

    Gibson, Maloney push NY Governor Cuomo to sign Lyme bill

    Click here:

    Once again, thanks to the Poughkeepsie Journal and to reporter, John Ferro, for their concern and efforts to get the Lyme bill passed.   PLEASE thank him by recommending and making a comment on the article!
    GREAT thanks are due to our Congressmen Gibson and Maloney for bringing this critical issue to Governor Cuomo by expressing their concerns in their letter to Governor Cuomo. They also worked to get HR4701 and many other bills passed in a bipartisan manner. These two are a prime example for all of our US Congress, doing what is right for constituents and the USA! Now Governor Cuomo, it is your turn to do what is right for NYS.  NY is the Empire State, it is time to act like it and lead the way! (read this article at the link at the top)
    As Karla Lehtonen commented:
    Let's get 10,000 emails to Cuomo! For more campaign info including a flyer, sample email to friends & family, bill info, FAQ, and NY Voices of Lyme facebook link: 
    Jill Auerbach
    Hudson Valley Lyme Disease Association, Chairperson
    NYS Coalition on Lyme and Tick-borne Disease, Member

    "What's the problem? Well it's the ticks of course!"